These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 9590209

  • 1. Involvement of SHP-2 in multiple aspects of IL-2 signaling: evidence for a positive regulatory role.
    Gadina M, Stancato LM, Bacon CM, Larner AC, O'Shea JJ.
    J Immunol; 1998 May 15; 160(10):4657-61. PubMed ID: 9590209
    [Abstract] [Full Text] [Related]

  • 2. IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3'-kinase, and Grb2.
    Gadina M, Sudarshan C, O'Shea JJ.
    J Immunol; 1999 Feb 15; 162(4):2081-6. PubMed ID: 9973481
    [Abstract] [Full Text] [Related]

  • 3. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
    Kim H, Baumann H.
    Mol Cell Biol; 1999 Aug 15; 19(8):5326-38. PubMed ID: 10409724
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A new tyrosine-phosphorylated 97-kDa adaptor protein mediates interleukin-2-induced association of SHP-2 with p85-phosphatidylinositol 3-kinase in human T lymphocytes.
    Gesbert F, Guenzi C, Bertoglio J.
    J Biol Chem; 1998 Jul 17; 273(29):18273-81. PubMed ID: 9660791
    [Abstract] [Full Text] [Related]

  • 6. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S, Volarevic S, Moriggl R, Mercep M, Groner B.
    Mol Endocrinol; 1998 Apr 17; 12(4):556-67. PubMed ID: 9544991
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ, O'Rourke DM, Feng GS, Johnson GR, Wang Q, Greene MI.
    Oncogene; 2001 Sep 20; 20(42):6018-25. PubMed ID: 11593409
    [Abstract] [Full Text] [Related]

  • 9. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    Ruhul Amin AR, Oo ML, Senga T, Suzuki N, Feng GS, Hamaguchi M.
    Cancer Res; 2003 Oct 01; 63(19):6334-9. PubMed ID: 14559821
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain.
    Adachi M, Ishino M, Torigoe T, Minami Y, Matozaki T, Miyazaki T, Taniguchi T, Hinoda Y, Imai K.
    Oncogene; 1997 Apr 03; 14(13):1629-33. PubMed ID: 9129156
    [Abstract] [Full Text] [Related]

  • 11. Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2.
    Arnaud M, Mzali R, Gesbert F, Crouin C, Guenzi C, Vermot-Desroches C, Wijdenes J, Courtois G, Bernard O, Bertoglio J.
    Biochem J; 2004 Sep 01; 382(Pt 2):545-56. PubMed ID: 15170389
    [Abstract] [Full Text] [Related]

  • 12. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
    Yu WM, Hawley TS, Hawley RG, Qu CK.
    Oncogene; 2003 Sep 04; 22(38):5995-6004. PubMed ID: 12955078
    [Abstract] [Full Text] [Related]

  • 13. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y, Akanuma Y, Yazaki Y, Kadowaki T.
    J Cell Physiol; 1999 Jan 04; 178(1):69-75. PubMed ID: 9886492
    [Abstract] [Full Text] [Related]

  • 14. A common requirement for the catalytic activity and both SH2 domains of SHP-2 in mitogen-activated protein (MAP) kinase activation by the ErbB family of receptors. A specific role for SHP-2 in map, but not c-Jun amino-terminal kinase activation.
    Deb TB, Wong L, Salomon DS, Zhou G, Dixon JE, Gutkind JS, Thompson SA, Johnson GR.
    J Biol Chem; 1998 Jul 03; 273(27):16643-6. PubMed ID: 9642214
    [Abstract] [Full Text] [Related]

  • 15. Immune signalling: SHP-2 docks at multiple ports.
    Huyer G, Alexander DR.
    Curr Biol; 1999 Feb 25; 9(4):R129-32. PubMed ID: 10074424
    [Abstract] [Full Text] [Related]

  • 16. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
    Vogel W, Ullrich A.
    Cell Growth Differ; 1996 Dec 25; 7(12):1589-97. PubMed ID: 8959326
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C, Susini C, Melmed S.
    J Clin Invest; 1999 Nov 25; 104(9):1277-85. PubMed ID: 10545526
    [Abstract] [Full Text] [Related]

  • 18. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
    Florio T, Yao H, Carey KD, Dillon TJ, Stork PJ.
    Mol Endocrinol; 1999 Jan 25; 13(1):24-37. PubMed ID: 9892010
    [Abstract] [Full Text] [Related]

  • 19. SHP-1 associates with both platelet-derived growth factor receptor and the p85 subunit of phosphatidylinositol 3-kinase.
    Yu Z, Su L, Hoglinger O, Jaramillo ML, Banville D, Shen SH.
    J Biol Chem; 1998 Feb 06; 273(6):3687-94. PubMed ID: 9452499
    [Abstract] [Full Text] [Related]

  • 20. Tyrosine phosphatase SHP-2 dephosphorylates the platelet-derived growth factor receptor but enhances its downstream signalling.
    Zhao R, Zhao ZJ.
    Biochem J; 1999 Feb 15; 338 ( Pt 1)(Pt 1):35-9. PubMed ID: 9931295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.